Sagimet Biosciences Ratios (2022-2026) | SGMT

Ratios Dec2022 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter) -1,204.70%
EBIT Margin (Quarter) -372.60%
EBITDA Margin (Quarter) -372.60%
Operating Margin (Quarter) -372.60%
Net Margin (Quarter) -1,204.70%
FCF Margin (Quarter) -193.95%
Efficiency
Assets Average (Quarter) 62.21M99.82M145.62M191.77M181.90M167.52M153.22M141.79M132.90M122.44M112.12M
Leverage & Solvency
Interest Coverage Ratio (Quarter) -1.85-0.33-0.42-0.17-0.00M-196.09-0.27-764.04-1.11-2.03-2.83-5.88
Times Interest Earned (Quarter) -1.85-0.33-0.42-0.17-0.00M-196.09-0.27-764.04-1.11-2.03-2.83-5.88
Valuation
Enterprise Value (Quarter) -32.34M-18.51M-101.84M-94.90M-193.71M-166.37M-152.49M-151.25M-144.57M-125.41M-116.69M-113.12M-104.54M
Return Ratios
Return on Sales (Quarter) -0.12%
Return on Capital Employed (Quarter) -50.14%-32.64%-33.39%-49.71%-51.97%-48.48%-45.62%
Return on Assets (Quarter) -0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%